|
Table 3: Neurological findings: neuropathic symptoms and monofilament assessment. |
||
|
Finding |
Total feet n (%) |
Patients n (%) |
|
Neuropathic symptoms – subjective |
||
|
Paresthesia |
459 (77.3) |
232 (76.8) |
|
Numbness |
393 (66.2) |
202 (66.9) |
|
Pain |
355 (59.8) |
183 (60.6) |
|
Burning sensation |
230 (38.7) |
117 (38.7) |
|
Semmes-Weinstein 10 g monofilament – objective |
||
|
Preserved |
559 (94.1) |
275 (91.1) |
|
Mildly reduced (1-3 insensate sites) |
22 (3.7) |
15 (5.0) |
|
Severely reduced (≥ 4 insensate sites) |
13 (2.2) |
12 (4.0) |
|
Any alteration |
35 (5.9) |
27 (8.9) |
|
Neuropathic symptoms reported by patient for any foot (right or left). A monofilament assessment was performed using a standardized 10-g Semmes-Weinstein monofilament at predefined plantar sites. Sensory function categorized as: preserved (0 insensate sites), mildly reduced (1-3 insensate sites), or severely reduced (≥ 4 insensate sites). Patient-level figures reflect the presence of findings in either foot. |
||